Skip to main content
Premium Trial:

Request an Annual Quote

Axon and Affymetrix to Co-Develop Next-Generation GeneChip Scanner

NEW YORK, March 19 - Just two months after Affymetrix rolled out its own GeneChip 3000 scanner, Axon instruments announced that the two companies will be co-developing a scanner that will handle future versions of Affymetrix GeneChip-brand microarrays.

 

Axon, of Union City, Calif.and Melbourne, Australia, will modify its ImageExpress high-throughput cellular screening system - a high-end instrument - for screening of the arrays, the company said. 

 

The instrument will be designed to scan arrays that are formatted in microwell plates, which Affymetrix said recently it was developing for large-scale testing and diagnostic applications. (See BioArray News article.)

 

Axon also said it has already delivered three customized ImageExpress instruments to Affymetrix, but did not disclose the financial terms of the agreement.

 

Affymetrix launched its own GeneChip 3000 instrument in January, just as an earlier agreement with competitor Agilent technologies, under which Agilent produced a scanner for Affymetrix, was set to expire.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.